Riskpilot← Back to searchSign inGet full accessOptalmica Gävle AB
ABDissolvedOrg 5593870693Medical specialists activities · NACE 8622Est. 20220 employees
Revenue 2025
SEK 13,1M
-36% vs 2024
EBITDA margin
11.4%
-60% vs 2024
Equity ratio
4.8%
Financial strength
Net profit 2025
SEK 206K
0 employees
| Revenue | SEK 13,1M | -36% |
| EBITDA | SEK 1,5M | -60% |
| Net profit | SEK 206K | — |
| Total assets | SEK 4,8M | -35% |
| Equity | SEK 230K | +821% |
| Employees | 0 | — |
Legal name
Optalmica Gävle AB
Org number
5593870693
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
30 juni 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva allmän hälso- och sjukvård, konsultation och rådgivning inom läkemedel- och sjukvårdsbranschen samt bedriva uthyrning av medicinteknisk utrustning och därmed förenlig verksamhet.
Address
Email
malin.westerberg@optalmica.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 4 820 | 20 626 | 13 125 |
| Staff expenses | — | — | −3 224 |
| EBITDA | −58 | 3 744 | 1 492 |
| Depreciation & amort. | −70 | −384 | −462 |
| EBIT | −128 | 3 360 | 1 030 |
| Net financials | −21 | −121 | −40 |
| Profit before tax | 0 | 4 | 261 |
| Tax | −0 | −4 | −56 |
| Net profit | 0 | 0 | 206 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 4 976 | 7 345 | 4 804 |
| Equity | 25 | 25 | 230 |
| Long-term debt | 2 100 | 5 088 | 3 229 |
| Short-term debt | 2 578 | 1 924 | 1 036 |
| Total debt | 4 678 | 7 012 | 4 265 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20232025
Equity ratio
4.8%
This company
38.2%
Market median
-87% vs market
20232025
Return on equity
89.3%
This company
18.4%
Market median
+385% vs market
20232025
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
20232025
Asset turnover
2.73×
This company
1.12×
Market median
+144% vs market
20232025
Debt / equity
19.86×
This company
0.62×
Market median
-3103% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EM Chief Executive Officer | Chief Executive Officer | 2022 |
JR Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Optalmica Holding AB
Optalmica Gävle AB Board members of Optalmica Gävle AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Malin Westerberg | Chief Executive Officer | 0 companies |
| Jens Roland Brehme | Audit | 0 companies |
| Zoi Papaioannou | Deputy Board Member | 0 companies |
| Nikolaos Merkoudis | Chairman | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |